Thomas J Kiernan

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting
    Thomas J Kiernan
    Cardiology Division, Section of Vascular Medicine and Cardiology Intervention, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, GRB 800, Boston, MA 02114, USA
    Cardiovasc Hematol Agents Med Chem 6:116-24. 2008
  2. ncbi Coronary artery restenosis: a paradigm of current treatment approaches
    T J Kiernan
    Section of Vascular Medicine and Cardiology Intervention, Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Minerva Cardioangiol 57:77-94. 2009
  3. ncbi The no-reflow phenomenon in the coronary circulation
    Thomas J Kiernan
    Division of Interventional Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Cardiovasc Hematol Agents Med Chem 7:181-92. 2009
  4. ncbi May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association
    Thomas J Kiernan
    Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Stroke 40:1502-4. 2009
  5. ncbi Combined pharmacomechanical thrombectomy for acute inferior vena cava filter thrombosis
    Bryan P Yan
    Cardiology Division, Section of Vascular Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Cardiovasc Revasc Med 9:36-40. 2008
  6. ncbi Treatment of renal artery in-stent restenosis with sirolimus-eluting stents
    Thomas J Kiernan
    Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Vasc Med 15:3-7. 2010
  7. ncbi Carotid duplex ultrasound velocity measurements versus intravascular ultrasound in detecting carotid in-stent restenosis
    Bryan P Yan
    Section of Vascular Medicine, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA
    Circ Cardiovasc Interv 2:438-43. 2009
  8. ncbi Endovascular management of acute limb ischemia
    Brian G Hynes
    Section of Vascular Medicine and Intervention, Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, USA
    Ann Vasc Surg 26:110-24. 2012
  9. ncbi Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option
    Ronan Margey
    Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Expert Rev Cardiovasc Ther 9:1347-60. 2011
  10. ncbi Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat"
    Thomas J Kiernan
    Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA
    Tech Vasc Interv Radiol 13:2-10. 2010

Collaborators

Detail Information

Publications21

  1. ncbi Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting
    Thomas J Kiernan
    Cardiology Division, Section of Vascular Medicine and Cardiology Intervention, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, GRB 800, Boston, MA 02114, USA
    Cardiovasc Hematol Agents Med Chem 6:116-24. 2008
    ..Current treatments to prevent restenosis include pharmacologic, mechanical and cellular approaches which we will discuss in this manuscript...
  2. ncbi Coronary artery restenosis: a paradigm of current treatment approaches
    T J Kiernan
    Section of Vascular Medicine and Cardiology Intervention, Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Minerva Cardioangiol 57:77-94. 2009
    ..Neointimal formation is the pathological basis for restenosis after coronary angioplasty and stenting. The authors discuss the current methods to treat and prevent coronary artery restenosis...
  3. ncbi The no-reflow phenomenon in the coronary circulation
    Thomas J Kiernan
    Division of Interventional Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Cardiovasc Hematol Agents Med Chem 7:181-92. 2009
    ..In this contemporary review we endeavour to discuss the pathophysiology of coronary no-reflow, understand the predictors and describe current pharmacological and mechanical strategies to prevent and treat coronary no-reflow...
  4. ncbi May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association
    Thomas J Kiernan
    Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Stroke 40:1502-4. 2009
    ..We aimed to investigate the incidence of May-Thurner syndrome in patients with cryptogenic stroke with patent foramen ovale...
  5. ncbi Combined pharmacomechanical thrombectomy for acute inferior vena cava filter thrombosis
    Bryan P Yan
    Cardiology Division, Section of Vascular Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Cardiovasc Revasc Med 9:36-40. 2008
    ..We report a case of IVC filter thrombosis with associated vena caval obstruction successfully treated with catheter-directed thrombolysis and adjunctive mechanical thrombectomy...
  6. ncbi Treatment of renal artery in-stent restenosis with sirolimus-eluting stents
    Thomas J Kiernan
    Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Vasc Med 15:3-7. 2010
    ..05). In conclusion, placement of a SES for the treatment of ISR in renal arteries is associated with high initial technical success but significant restenosis on duplex ultrasonography at follow-up...
  7. ncbi Carotid duplex ultrasound velocity measurements versus intravascular ultrasound in detecting carotid in-stent restenosis
    Bryan P Yan
    Section of Vascular Medicine, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA
    Circ Cardiovasc Interv 2:438-43. 2009
    ..Duplex ultrasonography criteria for assessing the severity of carotid artery (CA) in-stent restenosis are not well established...
  8. ncbi Endovascular management of acute limb ischemia
    Brian G Hynes
    Section of Vascular Medicine and Intervention, Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, USA
    Ann Vasc Surg 26:110-24. 2012
    ..This review will address the contemporary endovascular management of ALI encompassing pharmacologic and percutaneous interventional treatment strategies...
  9. ncbi Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option
    Ronan Margey
    Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Expert Rev Cardiovasc Ther 9:1347-60. 2011
    ..The results of renal artery stenting will be discussed and from this, the available noninvasive and invasive tools available to assess the clinical and hemodynamic significance of renal artery stenosis will be presented...
  10. ncbi Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat"
    Thomas J Kiernan
    Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA
    Tech Vasc Interv Radiol 13:2-10. 2010
    ..This article reviews the comprehensive diagnostic algorithm and medical treatment strategies for patients with infrainguinal PAD...
  11. ncbi Renal artery revascularization: collaborative approaches for specialists
    Thomas J Kiernan
    Department of Vascular Medicine and Intervention, Massachusetts General Hospital, Boston, MA 02114, USA
    Adv Chronic Kidney Dis 15:363-9. 2008
    ..Renal revascularization with a distal embolic protection device is a promising strategy in reducing the risk of atheroembolism and deterioration in kidney function...
  12. ncbi Directional coronary atherectomy: a time for reflection. Should we let it go?
    Roberto J Cubeddu
    Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    EuroIntervention 5:485-93. 2009
    ..In conclusion, we plead for its continued production and use as an interventional niche device for the wellbeing of our patients...
  13. ncbi ST-elevation myocardial infarction mortality in a major academic center "on-" versus "off-" hours
    Roberto J Cubeddu
    Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Invasive Cardiol 21:518-23. 2009
    ..However, the data are conflicting and, furthermore, inapplicable to hospitals where primary PCI is invariably performed...
  14. ncbi Difference in outcome among women and men after percutaneous mitral valvuloplasty
    Ignacio Cruz-Gonzalez
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Catheter Cardiovasc Interv 77:115-20. 2011
    ..To analyze the differences in anatomical, clinical and echocardiographic characteristics of women and men undergoing PMV and to evaluate the relationship between sex, PMV success, and immediate and long-term clinical outcome...
  15. ncbi Management of access site and systemic complications of percutaneous coronary and peripheral interventions
    Thomas J Kiernan
    Cardiology Division, Section of Vascular Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Invasive Cardiol 20:463-9. 2008
    ..Knowledge of common and specific procedural complications and their management are critical to successful outcomes. Complications can be classified as (i) access site-related and (ii) systemic...
  16. ncbi Enhancing back-up support during difficult coronary stent delivery: single-center case series of experience with the Heartrail II catheter
    Brian Hynes
    Vascular Medicine and Intervention, Division of Cardiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA
    J Invasive Cardiol 23:E43-6. 2011
    ..We report our preliminary experience using the 5 Fr Terumo guide catheter (Heartrail II, Terumo) from a single center...
  17. ncbi Covered stent for the treatment of recurrent bilateral renal artery in-stent restenosis
    Bryan P Yan
    Cardiology Division, Section of Vascular Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    J Invasive Cardiol 20:E288-92. 2008
    ..We present a case describing the use of a covered stent for the treatment of recurrent bilateral renal artery ISR after bare-metal and drug-eluting stent implantation and cutting-balloon angioplasty...
  18. ncbi Current status of pharmacological thrombolytic therapy and mechanical thrombectomy for the treatment of acute deep venous thrombosis
    Thomas J Kiernan
    Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
    Cardiovasc Hematol Agents Med Chem 7:12-8. 2009
    ..In this article, we attempt to perform a contemporary review of the literature pertaining to the use of thrombolytic therapy and endovascular thrombectomy in the treatment of acute DVT...
  19. ncbi Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease
    Thomas J Kiernan
    Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, Mass 02114, USA
    J Vasc Surg 50:431-9. 2009
    ..It is beyond the scope of this article to discuss antiplatelet treatment for other etiologies of stroke...
  20. ncbi Correlates of carotid stenosis in patients undergoing coronary artery bypass grafting--a case control study
    Thomas J Kiernan
    Department of Medicine, Division of Cardiology, Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Vasc Med 14:233-7. 2009
    ..Unlike previous studies, LMCA or extent of CAD did not correlate with significant carotid artery disease. Using these predictive models, a prospective outcomes trial is required to validate these criteria...
  21. ncbi Images in cardiovascular medicine. Over rehearsed: a cellist with Paget-Schroëtter
    Bryan P Yan
    Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston MA 02114, USA
    Circulation 118:e160-1. 2008